Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS Study.
Guzmán Y, Ríos J, Paredes J, Domínguez P, Maurel J, González-Abós C, Otero-Piñeiro A, Almenara R, Ladra M, Prada B, Pascual M, Guerrero MA, García-Granero Á, Fernández L, Ochogavia-Seguí A, Gamundi-Cuesta M, González-Argente FX, Pons LV, Centeno A, Arrayás Á, de Miguel A, Gil-Gómez E, Gómez B, Martínez JG, Lacy AM, de Lacy FB. Guzmán Y, et al. Among authors: maurel j. JAMA Surg. 2023 Sep 1;158(9):910-919. doi: 10.1001/jamasurg.2023.2521. JAMA Surg. 2023. PMID: 37436726
Late-occurring liver metastases in colorectal cancer.
Rodríguez-Moranta F, Castells A, Miquel R, Piñol V, Maurel J, Fuster J, Lacy AM, Piqué JM. Rodríguez-Moranta F, et al. Among authors: maurel j. Dig Dis Sci. 2005 Feb;50(2):345-7. doi: 10.1007/s10620-005-1608-y. Dig Dis Sci. 2005. PMID: 15745098 No abstract available.
Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado S, Maurel J, Piqué JM, Castells A. Rodríguez-Moranta F, et al. Among authors: maurel j. J Clin Oncol. 2006 Jan 20;24(3):386-93. doi: 10.1200/JCO.2005.02.0826. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365182 Clinical Trial.
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Martínez-Fernandez A, García-Albeniz X, Pineda E, Visa L, Gallego R, Codony-Servat J, Augé JM, Longarón R, Gascón P, Lacy A, Castells A, Maurel J. Martínez-Fernandez A, et al. Among authors: maurel j. Ann Surg Oncol. 2009 May;16(5):1412-20. doi: 10.1245/s10434-009-0405-9. Epub 2009 Mar 4. Ann Surg Oncol. 2009. PMID: 19259740 Clinical Trial.
[Evaluation of the efficacy and efficiency of a multidisciplinary unit for the treatment of patients with colorectal cancer].
Soriano A, Castells A, Lacy AM, Ayuso C, Ayuso JR, Conill C, Delgado S, Fuster J, García-Valdecasas JC, Ginès A, Martín M, Maurel J, Miquel R, Mollà M, Vilana R, Castellví-Bel S, Elizalde JI, Piñol V, Pellisé M, Biete A, Gascón P, Piqué JM. Soriano A, et al. Among authors: maurel j. Gastroenterol Hepatol. 2002 Dec;25(10):579-84. doi: 10.1016/s0210-5705(02)70319-1. Gastroenterol Hepatol. 2002. PMID: 12459118 Spanish.
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.
Ugidos L, Delgado S, Conill C, Ginés A, Gallego R, Ayuso JR, Miquel R, Tosca M, de Lacy A, Castells A, Maurel J. Ugidos L, et al. Among authors: maurel j. Invest New Drugs. 2009 Jun;27(3):262-8. doi: 10.1007/s10637-008-9192-6. Epub 2008 Oct 16. Invest New Drugs. 2009. PMID: 18923810 Clinical Trial.
The controversy of neoadjuvant therapy in rectal cancer.
Maurel J, Pedrosa L, Camps J. Maurel J, et al. Cir Esp (Engl Ed). 2019 Aug-Sep;97(7):361-363. doi: 10.1016/j.ciresp.2019.01.004. Epub 2019 Feb 14. Cir Esp (Engl Ed). 2019. PMID: 30773234 English, Spanish. No abstract available.
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.
Fernández-Martos C, Pericay C, Losa F, García-Carbonero R, Layos L, Rodríguez-Salas N, Martin-Richard M, Alonso-Orduña V, Vera R, Gallego J, Capdevila J, Salud A, Nogué M, Maurel J, Guash I, Montagut C, Lopez C, Macias I, Jain RK, Garcia-Albeniz X. Fernández-Martos C, et al. Among authors: maurel j. JAMA Oncol. 2019 Nov 1;5(11):1566-1573. doi: 10.1001/jamaoncol.2019.2294. JAMA Oncol. 2019. PMID: 31465088 Free PMC article.
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer.
Maurel J, Martin-Richard M, Conill C, Sánchez M, Petriz L, Ginès A, Miquel R, Gallego R, Cajal R, Ayuso C, Navarro S, Marmol M, Nadal C, Augé JM, Fernández-Cruz L, Gascón P. Maurel J, et al. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1391-8. doi: 10.1016/j.ijrobp.2006.07.008. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965868 Clinical Trial.
241 results